Viewing Study NCT01788020


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-02-25 @ 5:34 PM
Study NCT ID: NCT01788020
Status: COMPLETED
Last Update Posted: 2024-05-13
First Post: 2013-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
Sponsor: University of Ulm
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module